1403 related articles for article (PubMed ID: 33970839)
1. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
Chong ZZ; Souayah N
Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
[TBL] [Abstract][Full Text] [Related]
2. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
Thepmankorn P; Bach J; Lasfar A; Zhao X; Souayah S; Chong ZZ; Souayah N
Cytokine; 2021 Feb; 138():155404. PubMed ID: 33360025
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
5. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M
Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001
[TBL] [Abstract][Full Text] [Related]
6. Correspondence regarding: TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2.
Kaushik D; Bhandari R; Kuhad A
Expert Opin Ther Targets; 2021 Oct; 25(10):911. PubMed ID: 34761703
[No Abstract] [Full Text] [Related]
7. SARS-CoV-2 Invasion and Pathological Links to Prion Disease.
Lukiw WJ; Jaber VR; Pogue AI; Zhao Y
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139092
[TBL] [Abstract][Full Text] [Related]
8. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
9. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
10. An enlightening role for cytokine storm in coronavirus infection.
Zhao Z; Wei Y; Tao C
Clin Immunol; 2021 Jan; 222():108615. PubMed ID: 33203513
[TBL] [Abstract][Full Text] [Related]
11. [The neurology of COVID-19].
Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
[TBL] [Abstract][Full Text] [Related]
12. Nervous System Involvement in COVID-19: a Review of the Current Knowledge.
Norouzi M; Miar P; Norouzi S; Nikpour P
Mol Neurobiol; 2021 Jul; 58(7):3561-3574. PubMed ID: 33765290
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of COVID-19-induced cytokine storm in a young male patient with severe respiratory and neurological symptoms.
Muschitz C; Trummert A; Berent T; Laimer N; Knoblich L; Bodlaj G; Krainer A; Linder C; Resch H
Wien Klin Wochenschr; 2021 Sep; 133(17-18):973-978. PubMed ID: 33905029
[TBL] [Abstract][Full Text] [Related]
14. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
[TBL] [Abstract][Full Text] [Related]
15. Neurological manifestations and pathogenic mechanisms of COVID-19.
Galea M; Agius M; Vassallo N
Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
17. The role of HMGB1 in COVID-19-induced cytokine storm and its potential therapeutic targets: A review.
Wulandari S; Hartono ; Wibawa T
Immunology; 2023 Jun; 169(2):117-131. PubMed ID: 36571562
[TBL] [Abstract][Full Text] [Related]
18. Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm.
Mahmoud IS; Jarrar YB; Febrimarsa
Clin Exp Med; 2023 Oct; 23(6):2909-2923. PubMed ID: 37061574
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
[TBL] [Abstract][Full Text] [Related]
20. Neuro-COVID-19: an insidious virus in action.
Bratosiewicz-Wąsik J
Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
